Meta Pixel

News and Announcements

Anteo Diagnostics Ltd Signs Patent And Technology License Agreement With eBioscience

  • Published March 13, 2012 12:10AM UTC
  • Publisher Wholesale Investor
  • Categories Company Updates

Anteo Diagnostics Ltd announced that it has signed a Patent and Technology License Agreement with eBioscience, life sciences company, providing them with access to the Company’s Mix&Go technology. Under the terms of the agreement, Anteo will supply Mix&Go for use in the manufacture of biological reagents for all applicable markets in which the Company operates. Anteo will receive an initial upfront payment, fixed revenue for Mix&Go reagent supplied, and a royalty fee paid quarterly based on a percentage of worldwide net sales. eBioscience has undertaken technical assessment of the Mix&Go technology, performed due diligence and reached an agreement with great efficiency. The outcome could only occur with goodwill from both parties. Further, Anteo expects to be working in close collaboration with eBioscience into the future to ensure that all products that incorporate Mix&Go are delivered to the market promptly, that the technology is used across the eBioscience product range and that where applicable, Mix&Go is used in new products.

—–

To view the full article, please click here.

 

Company Updates
Dogs First to Reduce Risk: QBiotics’ Smarter Path to Oncology Markets

QBiotics took a compound derived from a north Queensland rainforest tree all the way to veterinary registration before pursuing human oncology to de-risk its human cancer programme. Interim CEO Ebru Davidson argues that sequence – now backed by early responses across several human cancers – is the company’s real asset. The story that pulled Wholesale […]

Company Updates
Built on discipline, not complexity: inside an ASX equities income strategy

Haydn Froggatt and Zac Brabin have decades of derivatives experience between them and access to almost any strategy in the market. They use two of the simplest structures available, and wrote 202 positions with them last year. Published by Fairway Capital Management. Based on an interview with co-founders Haydn Froggatt and Zac Brabin. Two traders, […]

Join over 45,000+ sophisticated investors

Join Now